Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 16,519 shares at $10.80 ($178K) on 2017-11-13, disclosed to the SEC on 2017-11-15.
Open-market sale of $178k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2017-01-20 | $35K | — | Filing → |
| ALDR | SELL | 2017-01-09 | $219K | — | Filing → |
| ALDR | SELL | 2017-01-09 | $51K | — | Filing → |